Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion type Assertion NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_head.
- NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion description "[A total of 76 cystic fibrosis patients with CFTR deltaF508 mutation (33 heterozygous and 43 homozygous) stratified according to normal glucose tolerance (NGT) (n = 51) or abnormal glucose homeostasis (AGH) (impaired fasting glucose, impaired glucose tolerance, or diabetes; n = 25) had their homeostasis model assessment (HOMA) of beta-cell function and of insulin sensitivity and hyperbolic product (beta-cell function x insulin sensitivity [B x S]) measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_provenance.
- NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion evidence source_evidence_literature NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_provenance.
- NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion SIO_000772 17337503 NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_provenance.
- NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion wasDerivedFrom befree-20140225 NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_provenance.
- NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_assertion wasGeneratedBy ECO_0000203 NP469075.RA-ykVlNa8rGM8EdSh1KjQmL9ISR5mnEtV2bQ0YXkd264130_provenance.